idexx lab deliv anoth quarter double-digit growth
updat forecast estim oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data oct
rate updat oct
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
steadili increas scale reach
veterinari diagnost lab busi dig narrow moat
well-posit benefit two key trend first pet ownership
continu grow household own pet
compar moreov pet owner
demonstr greater willing spend anim
tripl spend pet product servic
offer impress wide rang companion anim
diagnost test deliv mani form exampl carv
leadership posit single-us test kit in-offic use
conveni result less minut mani routin
recur diagnost switch outsid lab kit idexx
also maintain strong posit off-sit lab test anoth area
histor seen double-digit growth final enjoy
leadership posit in-hospit analyz focu
develop broaden menu test make
one-stop shop anim hospit uniqu abl
cross-sel mani product servic develop
strong sale organ provid tailor solut
abil sniff opportun build better mousetrap
cross smaller water-test production-animal-test
busi municip often requir routin test
water suppli offer uniqu test detect two
common bacteri contamin easier faster
use tradit test method allow firm
captur water market also
leader livestock poultri diagnost includ test
foot-and-mouth diseas although segment seen
growth consist pet busi gener
offer fatter margin anticip mani year growth ahead
rise incom emerg market feed appetit anim
protein like innov demonstr
expect come
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
idexx laboratori primarili develop manufactur distribut
diagnost product equip servic pet livestock key
product line includ single-us canin felin test kit veterinarian
employ offic benchtop chemistri hematolog analyz
test-panel analysi on-sit refer lab servic test detect
manag diseas livestock get revenu
outsid unit state
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
idexx lab deliv anoth quarter double-digit
post anoth strong quarter double-digit gain
top bottom line consist project
weve increment rais fair valu estim
per share mainli reflect time valu money sinc
last updat impress third-quart result
underscor strength idexx narrow econom moat
prudenc board long-stand practic
particip annual review execut success
plan think latter set stage
smooth transit weve seen incom ceo jay
mazelski far oper strategi yet
exhibit smallest hiccup transit period
pleas see consist grow above-market
portfolio companion anim
segment account nearli total revenu
led way quarterli organ revenu growth
driven vetlab consum refer lab happi
coincid smaller water product anim
segment also post robust organ growth
respect isnt usual case growth
segment lumpi respons diseas
outbreak chang local ordin
item caught attent manag call
first plan acquir marshfield lab upper
mid-west follow steadi stream central lab
acquisit reach current network lab
nationwid eas domest lab acquisit
last five year second expect enlarg
field forc anoth improv high-touch
support vet think decis
expand idexx capac meet steadili grow
increment increas fair valu estim
per share reflect cash flow realiz sinc
last updat expect double-digit growth
refer lab segment ad new rout
open possibl increas densiti rout
medium term thu bullish two
largest fastest-grow product line companion
anim segment boost aggress placement
instrument steadi stream new test assay
project averag consum growth
also estim refer lab growth averag
per year think growth sustain bar
major pullback economi consid
opportun cross-sel on-going progress
penetr new anim hospit analyz
instrument believ plenti potenti
sale consult sell new servic develop stickier
meantim continu roll new product
recept companion anim practic expect
averag annual growth companion anim segment
primarili fed adopt seri
new product larger base analyz sale ancillari
servic grow strength consum
refer lab consid adopt curv
in-hous diagnost equip tend slow steadi
sever year benefit string
new product launch deck next five
nonetheless even increas valuat share look
overpr us continu think takeout
premium inflat stock find difficult justifi
share trade revers engin
current share price wed need assum deliv
compound annual top-lin growth
basi point higher idexx three-year
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
pet healthcar market firm slip cost control
key rapid assay kit succumb competit bring
fair valu estim per share
leader point-of-car diagnost test
in-hous analyz equip hold well-establish
posit refer lab duopoli vca part
privat held mar econom moat driven
sever sourc first firm reli intellectu properti
protect know-how goe diagnost test
abil
consist innov diagnost test firm come
new gener test assay laboratori
equip test diseas appli
emerg diagnost technolog previous invent
human product anim water test well
companion anim product servic
typic focu test new type diseas
parasit improv turnaround time test result
increas accuraci result enhanc
conveni on-sit test firm also offer
integr vet practic manag softwar packag
simplifi transmiss test data patient medic
second moat bolster switch cost across
number product exampl
cornerston practic manag softwar
anim hospit staff invest time enter
patient client inform becom familiar
softwar inconveni instal learn
whole new system mean custom tend stick
principl appli in-hous test
equip practic instal base
equip train vet tech practic
like stick switch anoth brand
custom switch cost also rise vet practic
purchas multipl product servic
histor compound-annual-growth-rate addit firm would need deliv
basi point improv oper margin
next five year roughli basi point weve
alreadi bake valuat
base larg averag volatil cash flow
divers product portfolio rate uncertainti
new
base case assum abl expand
busi ahead market
adopt
instrument associ
consum strong refer lab perform drive
top-lin growth upsid growth
companion-anim segment reach
histor
double-digit level next five year -- outpac
market roughli basi point annual --
manufactur effici attain hike fair
valu estim per share
hand companion-anim segment growth
hover rang match long-term growth
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
exampl custom retent notic higher
practic combin refer lab in-hous
analyz softwar integr
final also enjoy cost advantag
diagnost lab extens scale larg
nation lab network abl run test lower
cost thank higher throughput volum ensu
effici use lab result attract margin
smaller-scal independ lab offer
rival vca antech creat duopoli market
built rout network dens
effici element contribut
moat render price tertiari factor
gain scale allow make serial
acquisit new competitor might emerg
seriou threat recent solidifi
posit production-anim segment europ
enter biomed clinic test market
acquisit radil acquir distributor brazil
sanofi bayer
see moat trend posit sever reason
production-anim diagnost market popul
group smaller pure-play compani pharmaceut
commercial-anim diagnost tini contributor
larger busi think unlik larg pharma
competitor focu much attent market
often seek much bigger profit fish fri even
anim health pharma pure-play zoeti tend focu
therapeut product companion product
anim smaller portfolio diagnost product
hand small pure play like advanc
anim diagnost could appeal purchas
companion-anim refer lab segment
vca primarili split domest market special
type lab test continu conduct anim
hospit lab associ veterinari school
major bread-and-butt test handl within
duopoli human refer laboratori giant quest
diagnost dip toe anim diagnost market
one refer lab east coast year ago quest
sinc refocus new opportun human
anim diagnost impress record
introduc innov thank robust spend
account estim spend
anim diagnost market made
attract partner pharmaceut firm would like
market therapi along companion
diagnost exampl boehring ingelheim team
market vetmedin treat congest heart failur
dog along cardiopet probnp test
provid earli detect heart failur anim medicin
continu move path pair therapi
diagnost expect highli sought
equip though diagnost test sent
refer lab result within follow two
day turnaround in-hous equip faster
conveni vet practic trade anim
hospit higher-margin in-hous test reap
financi reward even diagnost test
divert refer lab note
make steadi progress persuad practic use
competit in-hous analyz switch idexx
equip grow base instal unit bode well
continu stream consum revenu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
final think bold decis institut all-direct
distribut instrument consum rapid assay
kit histor sold tradit
vet distributor includ henri schein patterson
mwi paid long run although firm requir
increment invest build infrastructur
staff necessari support sale model expect
hold margin profit product
minim risk lose market share competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ounlik human healthcar pet health servic
reimburs issu price pressur
associ third-parti payer
oanecdot inform vet suggest
well-integr user-friendli practic manag
softwar help hospit switch stick
product servic
oidexx sale custom support staff garner high
mark provid high-touch servic vet practic
ointern sale account substanti chunk
total revenu dollar strengthen
would feel pain top bottom line
oidexx rapid assay product line vulner
competit pressur vet distributor
firm could see growth area stagnat declin
owhil cardiopet probnp seen impress uptak
thu far key veterinari cardiologist held
enthusiast endors vari
interpret test result across dog breed
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
financi health strong firm histor
fund expans acquisit primarili
cash gener held virtual long-term debt
unlik rival vca mani year ago ran
financi problem increas leverag fund
substanti expans taken financi
conserv approach consid firm throw
free cash flow percentag sale low-
mid-teen manag deploy strateg
acquisit share buyback firm decid
leverag balanc sheet increas debt roughli
time debt/ebitda manag target debt
remain rang intent use
cash fund share repurchas think level debt
manag especi consid
steadi cash flow hinder firm
flexibl choos pursu larger acquisit
opportun howev firm fell target
rang expect firm end
debt/ebitda shi time
base larg averag volatil cash flow
divers product portfolio rate uncertainti
medium medic diagnost technolog
remain vulner potenti technolog
consum spend
spend -- show less vet traffic reluct
spend diagnost well vet hold
purchas new upgrad equip
pressur livestock poultri product industri
may translat heighten competit less
negoti leverag time regulatori agenc
chang guidelin livestock poultri test
protein market suffer excess suppli
prolong low price rippl effect part
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
busi zoeti recent acquisit abaxi could
translat stiffer competit instrument
consum
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo/chairman board/
repres date owner name posit common share held report holder issuer
legal gener
new york mellon corp
share
fund
share
fund
think stewardship exemplari
outgo ceo chairman jonathan ayer step
role lead carrier unit unit
technolog seven year ayer step
follow seriou cycl accid remain
confid new ceo jay mazelski current cfo brian
handili execut
strategi serv well
fan level detail disclosur compani
provid well preponder outsid
eight-memb board includ lead director
like ceo requir report success plan
board least annual think definit paid
transit ceo gone remark
emphas restrict stock vest five year
point mazelski ownership share decent though
expect increas take ceo
respons think share ownership
director remain light would like see boost
stake put skin game
balanc think manag made wise
capital-alloc decis think rack
admir record acquisit made
number purchas make strateg sens
reason price includ bomm diagnost expand
footprint product anim diagnost across europ
dvminsight bolster telemedicin capabl
radil gain foothold biomed research market
perhap
manag will pass deal
opportun enhanc valu asid
merger acquisit like manag
intern
consist upgrad instrument roll new assay
panel importantli partner vet main
staf train
import
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
critic stewardship focus share
repurchas mainli stock typic bought
premium valuat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
idexx lab deliv anoth quarter double-digit
post anoth strong quarter double-digit gain
top bottom line consist project
weve increment rais fair valu estim
per share mainli reflect time valu money sinc
last updat impress third-quart result
underscor strength idexx narrow econom moat
prudenc board long-stand practic
particip annual review execut success
plan think latter set stage
smooth transit weve seen incom ceo jay
mazelski far oper strategi yet
exhibit smallest hiccup transit period
pleas see consist grow above-market
portfolio companion anim
segment account nearli total revenu
led way quarterli organ revenu growth
driven vetlab consum refer lab happi
coincid smaller water product anim
segment also post robust organ growth
respect isnt usual case growth
segment lumpi respons diseas
outbreak chang local ordin
item caught attent manag call
first plan acquir marshfield lab upper
mid-west follow steadi stream central lab
acquisit reach current network lab
nationwid eas domest lab acquisit
last five year second expect enlarg
field forc anoth improv high-touch
support vet think decis
expand idexx capac meet steadili grow
narrow-moat lab announc long-tim ceo jon
ayer would leav ceo chairman posit
follow seriou spinal cord injuri sustain
cycl accid summer expect incom
manag larg follow success playbook
ayer leav behind maintain fair valu
consid well-establish idexx strategi think
incom ceo presid jay mazelski unlik
make dramat chang mazelski bring consider
diagnost life scienc experi
time philip healthcar agil import
join seven year ago lead north
american companion anim commerci oper
 pet diagnost busi arguabl
import piec account nearli total
revenu estim similar level idexx oper
think mazelski key part
strengthen competit advantag
weve discuss past one idexx sourc
narrow moat stem intang asset asid
patent proprietari knowledg goe creat
diagnost equip perhap import
relationship idexx field forc abl
cultiv veterinarian vet typic get
train vet school equip run anim
hospit small busi provid support
high-touch custom servic practic
manag softwar consult servic help
anim hospit run effici profit
value-ad level servic strength
even no-nam competitor may offer
compar test panel roughli idexx price
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
anticip mazelski continu invest idexx field
forc like export model outsid
may biggest risk point pullback pet
remain confid idexx moat trend remain
posit firm continu strengthen bond
program anoth exampl firm partner close
veterinarian help build practic
roughli practic sign program
provid coach vet train
staff market materi educ client
valu prevent diagnost trail
basi practic particip program post
growth companion diagnost revenu compar
overal custom diagnost test
sourc high-margin revenu anim hospit
program help add valu client
post strong stellar aug
idexx lab post strong second-quart result fell
slightli short consist stellar perform
investor come expect firm
anticip modest bump fair valu estim
adjust slightli slower top-lin growth off-set
better-than-expect expens control share remain
highli overvalu opinion remain big fan
idexx narrow econom moat built cost advantag
intang asset idexx corpor cultur focus
partner veterinarian way anim
healthcar firm embrac anticip
particular strength becom evid
come quarter time interim ceo jay
mazelski taken rein long-stand ceo jon
ayer extend medic leav would highli
surpris see make misstep ayer absenc
quarter quarter outpac pet healthcar
market double-digit organ top-lin growth
year year led double-digit growth high-
margin consum refer lab busi
see littl chang view sustain
nonetheless display rare sign soft part
intern busi specif catalyst
upgrad product anim revenu china think
two situat reflect slow econom growth
current outbreak african swine fever china
particularli concern though sinc china isnt
materi driver firm fortun
 vet offic traffic remain respect second
quarter clinic visit practic revenu
year year believ recessionari condit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
